The Block Grant Consolidation's Hidden Cut Is in the Mandates, Not the Number

In January 2026, SAMHSA sent termination notices to somewhere between 2,000 and 2,900 grantees, covering approximately $2 billion in behavioral health funding. Within 24 hours, the notices were reversed. The FY2026 final appropriations settled at roughly $7.4 billion for SAMHSA — approximately level with the prior year. The January chaos was treated, in most press coverage, as a scare that ended well.

That framing misses what’s still on the table.

The administration’s FY2026 budget proposal, which has not been fully abandoned, consolidates the Community Mental Health Services Block Grant, the Substance Use Prevention, Treatment, and Recovery Services Block Grant, and the State Opioid Response grants into a single new vehicle: the Behavioral Health Innovation Block Grant, funded at $4.126 billion. The categorical programs it replaces ran to over $4.6 billion. On paper, that’s a nominal cut of roughly $465 million, or about 10%. The stated rationale is flexibility — states get fewer strings, a single check, more local control.

The problem with that framing is that categorical mandates aren’t bureaucratic friction. They’re the mechanism that pushes money toward the things voluntary state spending won’t cover.

Look at what lived in the categorical programs that would be eliminated or folded under the BHIBG: workforce development grants, mandatory set-asides for syringe service programs in states that have them, data collection requirements for overdose surveillance, and — critically — the 17 grants of regional and national significance that fund harm reduction infrastructure like the fentanyl test strip distribution programs already under pressure from the federal ban’s partial reversal. States that are ideologically opposed to syringe services or harm reduction don’t face those categorical requirements under a block grant. States that are willing don’t have the same guaranteed floor of federal investment.

The SAMHSA-funded national hotlines, the Suicide & Crisis Lifeline coordination, the peer specialist training programs — these all live inside categorical structures. None of them are guaranteed to survive a formula-based block grant at the discretion of state health agencies operating under completely different political environments.

This isn’t an argument against flexibility in principle. It’s an argument about what flexibility actually means when the thing you’re making more flexible is a funding stream that was categorical because states wouldn’t fund it otherwise. The January termination reversal was a reprieve. The underlying policy debate hasn’t moved.

Rize tracks federal policy changes as they reach treatment access in Arizona. AHCCCS currently covers all three FDA-approved medications for opioid use disorder, and Arizona has been expanding harm reduction funding. Under a block grant, Arizona’s current posture would be protected — but the guarantee would be weaker than it is today, and changes in state leadership would face less federal constraint.